Europe Hormone Replacement Therapy Market Forecasts (2016–2021)
Europe Hormone Replacement Therapy Market by Hormone Type (Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Replacement Therapy and Others) by Route of Administration
(EMAILWIRE.COM, January 05, 2018 ) Europe Hormone Replacement Therapy (HRT) in postmenopausal women is generally defined as treatment with estrogen or a combination of oestrogen plus progestogen. In 2016, the Europe Hormone Replacement Therapy Market is valued at USD 4.10 billion and is predicted to become a USD 5.68 billion market by 2021, growing at a CAGR of 6.75%.
View Full Report @ https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/
The key growth driver of the Europe hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are availability and development novel formulations, presence of unmet medical needs which require the employment of hormone therapy.
Request Sample @ https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/request-sample
However, the risk of side effects, such as bleeding, bloating, mood changes, and nausea, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is blocking the growth of the market. Along with this, high cost of therapy is acting as a major hurdle. This is limiting its reach to middle class consumers especially in the emerging nations of Central and Eastern Europe. Further, women with high susceptibility to coronary diseases, who are present in significant numbers in the European countries are kept away from taking hormone replacement therapy.
The Europe hormone replacement therapy market is analysed on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates the Europe market. The largest consumers of estrogen replacement therapy are post-menopausal women. Growth hormone therapy is used for children, while thyroid replacement therapies are applied to elderly people. Further, on the basis of route of administration the market is segregated under oral, parenteral, transdermal and other routes. The oral route of administration is regarded as one of the safest and most preferred routes of drug administration.
Inquire Before Buy @ https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/inquire
Further, on the basis of geography, the hormone replacement therapy market is analysed under countries namely, United Kingdom, France, Germany, Italy and Spain. France provides ample opportunities for hormone replacement therapy industry and with more than 50% of the women with menopause symptoms are reported to take hormone replacement therapy.
Buy Now @ https://www.marketdataforecast.com/cart/buy-now/europe-hormone-replacement-therapy-market-960
Some of the key players of hormone replacement industry operating in the European Region are Pfizer, Mylan Laboratories, Novartis, Merck & Co., Bayer, Amgen, Eli Lily, Novo Nordisk, F. Hoffmann-La Roche, Abbott Laboratories, Wyeth and Hisamitsu Pharmaceutical Co. Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
View Full Report @ https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/
The key growth driver of the Europe hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are availability and development novel formulations, presence of unmet medical needs which require the employment of hormone therapy.
Request Sample @ https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/request-sample
However, the risk of side effects, such as bleeding, bloating, mood changes, and nausea, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is blocking the growth of the market. Along with this, high cost of therapy is acting as a major hurdle. This is limiting its reach to middle class consumers especially in the emerging nations of Central and Eastern Europe. Further, women with high susceptibility to coronary diseases, who are present in significant numbers in the European countries are kept away from taking hormone replacement therapy.
The Europe hormone replacement therapy market is analysed on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates the Europe market. The largest consumers of estrogen replacement therapy are post-menopausal women. Growth hormone therapy is used for children, while thyroid replacement therapies are applied to elderly people. Further, on the basis of route of administration the market is segregated under oral, parenteral, transdermal and other routes. The oral route of administration is regarded as one of the safest and most preferred routes of drug administration.
Inquire Before Buy @ https://www.marketdataforecast.com/market-reports/europe-hormone-replacement-therapy-market-960/inquire
Further, on the basis of geography, the hormone replacement therapy market is analysed under countries namely, United Kingdom, France, Germany, Italy and Spain. France provides ample opportunities for hormone replacement therapy industry and with more than 50% of the women with menopause symptoms are reported to take hormone replacement therapy.
Buy Now @ https://www.marketdataforecast.com/cart/buy-now/europe-hormone-replacement-therapy-market-960
Some of the key players of hormone replacement industry operating in the European Region are Pfizer, Mylan Laboratories, Novartis, Merck & Co., Bayer, Amgen, Eli Lily, Novo Nordisk, F. Hoffmann-La Roche, Abbott Laboratories, Wyeth and Hisamitsu Pharmaceutical Co. Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results